Page last updated: 2024-09-05

nbi 27914 and fulvestrant

nbi 27914 has been researched along with fulvestrant in 1 studies

Compound Research Comparison

Studies
(nbi 27914)
Trials
(nbi 27914)
Recent Studies (post-2010)
(nbi 27914)
Studies
(fulvestrant)
Trials
(fulvestrant)
Recent Studies (post-2010) (fulvestrant)
760292,7122071,196

Protein Interaction Comparison

ProteinTaxonomynbi 27914 (IC50)fulvestrant (IC50)
Estrogen receptorHomo sapiens (human)0.0061
Estrogen receptorRattus norvegicus (Norway rat)0.0059
Progesterone receptorHomo sapiens (human)0.0002
Steroid hormone receptor ERR1Homo sapiens (human)0.002
Bifunctional epoxide hydrolase 2Homo sapiens (human)0.006
Estrogen receptor betaHomo sapiens (human)0.0104
Bile acid receptorHomo sapiens (human)0.79
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)2.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T; Forman, BM; Lin, W; Yu, DD1

Other Studies

1 other study(ies) available for nbi 27914 and fulvestrant

ArticleYear
Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.
    Bioorganic & medicinal chemistry, 2013, Jul-15, Volume: 21, Issue:14

    Topics: Biological Assay; Drug Discovery; Fluoresceins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Gene Expression Regulation; Isoxazoles; Molecular Structure; Protein Binding; Receptors, Cytoplasmic and Nuclear

2013